Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

OXYTROL FOR WOMEN 3.9 MG/24HR

Oxybutynin
$2.7368per EA
OTC

Strength

3.9 mg/d

Manufacturer

Allergan, Inc.

NDC

00023963708

Classification

Brand

Dosage Form

PATCH

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

OXYBUTYNIN

Approval Type

New Drug (NDA)

FDA Application

NDA202211

On Market Since

1/1/2016

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price History

1W

0.0%

1M

+0.8%

3M

-0.4%

6M

-0.1%

1Y

-0.3%

3Y

+2.0%

5Y

+0.2%

All

-1.5%

Generic Alternatives

1 alternative • Same active ingredient

OXYTROL FOR WOMEN 3.9 MG/24HR
Brand
00023963704•Allergan, Inc.
$2.7368

Related Drugs

Same classification

CUVPOSA 1 MG/5 ML SOLUTION
Brand
00259050116•Merz Pharmaceuticals, LLC
$1.0081
per ML
VESICARE LS 5 MG/5 ML SUSP
Brand
51248025099•Astellas Pharma US, Inc.
$1.6383
per ML
LOMOTIL 2.5-0.025 MG TABLET
Brand
00025006131•Pfizer Inc.
$3.0028
per EA
MOTOFEN 1-0.025 MG TABLET
Brand
54766020010•Sebela Pharmaceuticals Inc.
$6.9129
per EA
VESICARE 5 MG TABLET
Brand
51248015001•Astellas Pharma US, Inc.
$12.2839
per EA
VESICARE 10 MG TABLET
Brand
51248015101•Astellas Pharma US, Inc.
$12.2924
per EA
DETROL LA 4 MG CAPSULE
Brand
58151010477•Viatris Specialty LLC
$13.2274
per EA
DETROL LA 4 MG CAPSULE
Brand
58151010493•Viatris Specialty LLC
$13.2274
per EA
QBREXZA 2.4% CLOTH
Brand
69489041130•Journey Medical Corporation
$20.5973
per EA
COBENFY 100 MG-20 MG CAPSULE
Brand
00003110060•E.R. Squibb & Sons, L.L.C.
$30.3016
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy